Health-tech startup Biopeak has raised $2.7 million in a follow-on funding round led by NKSquared, the investment vehicle of Zerodha cofounder Nikhil Kamath, as it continues to scale its longevity and preventive care offerings in India’s burgeoning health ecosystem. This marks Kamath’s second investment in the Bengaluru-based startup following an earlier infusion of $1.43 million in August 2024.

Co-founded in 2025 by Rishi Pardal and Shiva Subramanian, Biopeak focuses on extending healthy lifespans through a unique blend of multidisciplinary diagnostics, AI-driven insights, and personalised clinical programmes. Its platform integrates advanced tools such as imaging, molecular profiling, microbiome mapping, and wearable data to deliver tailored health optimisation plans.

The fresh capital will be used to expand the startup’s operations, including opening additional clinics, enhancing proprietary AI diagnostics, bolstering research initiatives, and growing clinical and product teams. Biopeak also plans to strengthen collaborations with global advisors to refine its clinical protocols and accelerate evidence-based care delivery.

Over the past year, Biopeak has broadened its clinical programmes and client base amid rising demand for structured longevity services, and it is planning to open a second clinic soon in Bengaluru.